CASP9 and in situ carcinoma: Control group and EMPA treated group showed negative to weak immunoreaction for caspase-9 in granulosa cells, while in CIS group showed a strong immunoreaction in granulosa cells, co-administration of EMPA with CIS lead to a negative reaction similar to the control group as well (Fig. 3).